Back to search

University of Thessaly (UTH)

Μελέτη φυσικών και συνθετικών ενώσεων με αντιγηραντική δράση και δράση εναντίον της πρωτεϊνικής συσσωμάτωσης σε οργανισμικά και κυτταρικά μοντέλα γήρανσης

Abstract

dc:description

In this doctoral thesis, we studied two compounds that structurally activate the 20S proteasome, likely through direct stereochemical interactions. These compounds demonstrated anti-aging properties and reduced protein aggregation in cellular and organismal aging models. In the first part of the thesis, we identified for the first time a natural compound isolated from the brown alga Dictyota mediterranea as a structural proteasome activator, named (1R,3E,6R,7Z,11S,12S)-dolabella-3,7,18-trien-6,17-olide (DBTO). DBTO activates the 20S proteasome both in vitro (in the absence of cell lysates) and in cellulo. Continuous administration of DBTO to young, human primary fibroblasts (HFL-1) throughout their replicative lifespan improves cellular healthspan. Similarly, DBTO administration improves the health status of wild-type Caenorhabditis elegans nematodes. Furthermore, DBTO administration in transgenic Alzheimer’s disease models of C. elegans and human neuroblastoma cells (SH-SY5Y) exposed to Aβ peptide enhances protection against Aβ-induced proteotoxicity.In the second part of the thesis, the hybrid compound MK151, combining the structural features of hydroxytyrosol and chroman (the pharmacophore of vitamin E) in one scaffold, was identified as a structural 20S proteasome activator in vitro (in the absence of cell lysates), in cellulo, and in vivo following administration in wild-type C. elegans. Continuous MK151 administration to young, human primary fibroblasts (HFL-1) throughout their replicative lifespan extends lifespan and improves cellular healthspan. Likewise, improvement of organismal healthspan is also observed in wild-type C. elegans nematodes treated with MK151. Additionally, MK151 administration in transgenic Alzheimer’s disease models of C. elegans provides enhanced protection against Aβ-induced proteotoxicity. Moreover, the synthesis of optimized MK151 analogs yielded compounds that structurally activate the 20S proteasome in vitro (in the absence of cell lysates) and exhibit similar or even superior anti-aging and/or neuroprotective effects in C. elegans and human primary fibroblasts (HFL-1). In total, our results reveal two structural proteasome activators: DBTO, a metabolite derived from a Mediterranean marine organism and the bio-inspired synthetic compound MK151, highlighting their potential as agents to improve or preserve healthspan and provide preventive protection against age-related diseases characterized by protein aggregation, such as Alzheimer’s disease.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vasilopoulou, Maria
  • Βασιλοπούλου, Μαρία

Subjects

dc:subject × 33

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59870

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vasilopoulou, Maria; Βασιλοπούλου, Μαρία. Μελέτη φυσικών και συνθετικών ενώσεων με αντιγηραντική δράση και δράση εναντίον της πρωτεϊνικής συσσωμάτωσης σε οργανισμικά και κυτταρικά μοντέλα γήρανσης. University of Thessaly (UTH), 2025. http://hdl.handle.net/10442/hedi/59870